{
    "organizations": [],
    "uuid": "2f4935aa0c3b45230a786dce597010e013ab4cfc",
    "author": "",
    "url": "https://www.reuters.com/article/brief-edwards-says-its-self-expanding-tr/brief-edwards-says-its-self-expanding-transcatheter-heart-valve-receives-ce-mark-idUSFWN1Q50RK",
    "ord_in_thread": 0,
    "title": "BRIEF-Edwards Says Its Self-Expanding Transcatheter Heart Valve Receives CE Mark",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 15, 2018 / 1:13 PM / in 10 minutes BRIEF-Edwards Says Its Self-Expanding Transcatheter Heart Valve Receives CE Mark Reuters Staff 1 Min Read Feb 15 (Reuters) - Edwards Lifesciences Corp: * GOT CE MARK FOR SELF-EXPANDING CENTERA VALVE FOR SEVERE, SYMPTOMATIC AORTIC STENOSIS PATIENTS AT HIGH RISK OF OPEN-HEART SURGERY * CENTERA VALVE IS NOT APPROVED FOR COMMERCIAL SALE IN U.S. Source text for Eikon: Further company coverage:",
    "published": "2018-02-15T15:13:00.000+02:00",
    "crawled": "2018-02-15T15:43:19.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "minute",
        "say",
        "transcatheter",
        "heart",
        "valve",
        "receives",
        "ce",
        "mark",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "edward",
        "lifesciences",
        "corp",
        "got",
        "ce",
        "mark",
        "centera",
        "valve",
        "severe",
        "symptomatic",
        "aortic",
        "stenosis",
        "patient",
        "high",
        "risk",
        "surgery",
        "centera",
        "valve",
        "approved",
        "commercial",
        "sale",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}